Cover Image

The case for levetiracetam to be included in essential medicine lists

Saved in:

Bibliographic Details
Main Authors:	Gagandeep Singh (Author), Josemir W. Sander (Author)
Format:	Book
Published:	Elsevier, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Essential medicine list 2011
by: Keshab Mukhopadhyay, et al.
Published: (2014)

Essential medicine list 2011
by: Keshab Mukhopadhyay, et al.
Published: (2014)

On Essentiality and the World Health Organization's Model List of Essential Medicines
by: Victoria A. Marks, et al.
Published: (2017)

A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename)
by: Helena Lutéscia L. Coelho, et al.
Published: (2013)

A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename)
by: Helena Lutéscia L. Coelho, et al.
Published: (2013)

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024)

Biologic medicine inclusion in 138 national essential medicines lists
by: Raphaël Kraus, et al.
Published: (2021)

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
by: Marzieh Zargaran, et al.
Published: (2016)

WHO to launch first essential medicines list for children
by: Theresa Braine
Published: (2007)

A comparison of national essential medicines lists in the Americas
by: Liane Steiner, et al.
Published: (2020)

Revising the WHO Essential Medicines List for paediatric rheumatology
by: Christiaan Scott, et al.
Published: (2021)

Essential medicine list in India, 2022: A recent update
by: U. Sharath, et al.
Published: (2023)

Revising the WHO Essential Medicines List for paediatric rheumatology update
by: Waheba Slamang, et al.
Published: (2022)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
by: Wenbin Liu, et al.
Published: (2019)

A human rights approach to the WHO Model List of Essential Medicines
by: Seuba Xavier
Published: (2006)

"Circle of good" included the new nosology in its list
by: article Editorial
Published: (2023)

Implementing WHO's Intersectoral Global Action Plan for epilepsy and other neurological disorders in Southeast Asia: a proposal
by: Gagandeep Singh, et al.
Published: (2023)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
by: Ayo-Oley Baldeh, et al.
Published: (2023)

The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines-Taking Oncology Medicines as an Example
by: Luyan Cheng, et al.
Published: (2022)

Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
by: Beatrice Todesco, et al.
Published: (2023)

NOACs Added to WHO's Essential Medicines List: Recommendations for Future Policy Actions
by: Mariachiara Di Cesare, et al.
Published: (2020)

Levetiracetam induced hypomania: a case report
by: Ali Ercan Altınöz, et al.
Published: (2019)

National Essential Medicines List and policy practice: A case study of China's health care reform
by: Tian Xin, et al.
Published: (2012)

International Variations In Essential Medication Lists
by: Ali H. Tejani, et al.
Published: (2014)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
by: Ian Naicker, et al.
Published: (2022)

<i>Spina bifida</i> is included in the orphan disease list
by: article Editorial
Published: (2023)

Safety assessment of medicines available in the 'Brazilian list of essential medicines' in the older persons according to the Beers Criteria
by: Francelle Adorno Sôffa Guimarães Monteiro, et al.
Published: (2023)

The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
by: S. Manikandan
Published: (2023)

The "Square Box": Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
by: Bernadette Cappello, et al.
Published: (2020)

The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia
by: Fatih Kahraman, et al.
Published: (2015)

Effect of Levetiracetam on Motor Learning
by: J Gordon Millichap
Published: (2003)

Levetiracetam in Landau-Kleffner Syndrome
by: J Gordon Millichap
Published: (2003)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009)

Free acquisition of psychotropic drugs by the Brazilian adult population and presence on the National List of Essential Medicines
by: Patrícia Silveira Rodrigues, et al.
Published: (2022)

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
by: Jose-Manuel de, et al.
Published: (2020)

Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
by: Dragos A. Nita, et al.
Published: (2016)

Efficacy of levetiracetam in refractory childhood epilepsy
by: Keon Su Lee, et al.
Published: (2010)

Cost analysis of different antibiotic brands available in indian market with reference to National List of Essential Medicines
by: Dinesh Kumar Meena, et al.
Published: (2021)

Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil
by: Caiyun Li, et al.
Published: (2024)